auro-efavirenz tablet
auro pharma inc - efavirenz - tablet - 600mg - efavirenz 600mg - nonnucleoside reverse transcriptase inhibitors
mylan-efavirenz tablet
mylan pharmaceuticals ulc - efavirenz - tablet - 600mg - efavirenz 600mg - nonnucleoside reverse transcriptase inhibitors
tenofovir disoproxil emtricitabine efavirenz viatris
viatris limited - efavirenz 600mg; ; emtricitabine 200mg; ; tenofovir disoproxil maleate 300mg equivalent to 245 mg tenofovir disoproxil - film coated tablet - active: efavirenz 600mg emtricitabine 200mg tenofovir disoproxil maleate 300mg equivalent to 245 mg tenofovir disoproxil excipient: colloidal silicon dioxide croscarmellose sodium hyprolose low-substituted hydroxypropylcellulose, lh 11 iron oxide red lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 85f540043 sodium metabisulfite - indicated for the treatment of hiv infected adults over the age of 18 years, alone or in combination with other antiretroviral agents.
tenofovir disoproxil/emtricitabine/efavirenz viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle
alphapharm pty ltd - emtricitabine, quantity: 200 mg; efavirenz, quantity: 600 mg; tenofovir disoproxil maleate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium metabisulfite; hyprolose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; ferric oxide; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - tenofovir disoproxil/ emtricitabine/ efavirenz mylan 300/200/600 is indicated for the treatment of hiv infected adults over the age of 18 years.,this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts in controlled studies of viread, emtriva and stocrin in treatment-na?ve and treatment experienced adults.
stocrin efavirenz 30mg/ml oral solution bottle
merck sharp & dohme (australia) pty ltd - efavirenz -
efavirenz 600 mg emtricitabine 200 mg & tenofovir film-coated tablet
macleods pharmaceuticals limited atlanta arcade church road andheri-kurla road - efavirenz 600 mg emtricitabine 200 mg & tenofovir - film-coated tablet - each film coated tablet contains efavirenz usp - antivirals for systemic use: combinations of
sustiva
bristol-myers squibb pharma eeig - efavirenz - hiv infections - antivirals for systemic use - sustiva is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children three years of age and older.sustiva has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease-inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with pis has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing sustiva.
sandoz efavirenz/emtricitabine/tenofovir tablet
sandoz canada incorporated - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
apo-efavirenz-emtricitabine-tenofovir tablet
apotex inc - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
mylan-efavirenz/emtricitabine/tenofovir disoproxil fumarate tablet
mylan pharmaceuticals ulc - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors